AVR

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Held by: IWM VXF IWO VTWO IWC VTWG RSSL FSYD VTHR UWM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.34	Insider Own	38.97%	Shs Outstand	36.06M	Perf Week	-8.04%
Market Cap	226.17M	Forward P/E	-	EPS next Y	-1.24	Insider Trans	0.00%	Shs Float	25.14M	Perf Month	10.91%
Enterprise Value	219.06M	PEG	-	EPS next Q	-0.50	Inst Own	74.02%	Short Float	6.38%	Perf Quarter	30.40%
Income	-84.32M	P/S	105.69	EPS this Y	38.50%	Inst Trans	3.00%	Short Ratio	2.02	Perf Half Y	52.08%
Sales	2.14M	P/B	53.54	EPS next Y	45.21%	ROA	-419.74%	Short Interest	1.60M	Perf YTD	10.02%
Book/sh	0.10	P/C	24.80	EPS next 5Y	34.80%	ROE	-2462.70%	52W High	8.79 -37.54%	Perf Year	-11.45%
Cash/sh	0.22	P/FCF	-	EPS past 3/5Y	-57.99% -	ROIC	-1582.23%	52W Low	2.34 134.62%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.10% -	Gross Margin	7.10%	Volatility	7.89% 9.21%	Perf 5Y	-
Dividend TTM	-	EV/Sales	102.36	EPS Y/Y TTM	-18.32%	Oper. Margin	-4041.29%	ATR (14)	0.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.80	Sales Y/Y TTM	-21.10%	Profit Margin	-3941.69%	RSI (14)	49.14	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	0.84	EPS Q/Q	-1.41%	SMA20	-2.17%	Beta	1.61	Target Price	15.25
Payout	-	Debt/Eq	0.64	Sales Q/Q	-44.21%	SMA50	6.59%	Rel Volume	1.26	Prev Close	5.22
Employees	136	LT Debt/Eq	0.44	Earnings	Nov 11 AMC	SMA200	23.73%	Avg Volume	793.01K	Price	5.49
IPO	Dec 13, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.33% 7.25%	Trades		Volume	996,640	Change	5.17%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Initiated	Lake Street	Buy	$20
Jan-07-25	Initiated	TD Cowen	Buy	$15
Jan-07-25	Initiated	Cantor Fitzgerald	Overweight	$9
Jan-07-25	Initiated	Barclays	Overweight	$22

Jan-24-26 09:01AM	Anteris Technologies price target lowered to $15 from $20 at Lake Street (TipRanks)
Jan-22-26 04:02PM	Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises (GlobeNewswire) +8.42%
04:01PM	Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock (GlobeNewswire)
11:28AM	Anteris Technologies announces $200M public offering to fund clinical growth (Proactive)
Jan-21-26 05:50AM	Medtronic to buy up to $90M stake in heart valve developer Anteris (MedTech Dive) +5.39%
01:38AM	Loading…
01:38AM	What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours? (Benzinga)
Jan-20-26 10:53PM	Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering (GlobeNewswire) +12.52%
04:01PM	Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic (GlobeNewswire)
Nov-17-25 06:00AM	Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves (GlobeNewswire)
Nov-12-25 05:52PM	Anteris Announces Results for the Third Quarter of 2025 (GlobeNewswire)
Nov-03-25 07:00AM	FDA Approves Anteris's DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") (GlobeNewswire)
Oct-28-25 06:08PM	Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year (GlobeNewswire) -7.84% -8.71%
Oct-27-25 05:43PM	Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") (GlobeNewswire)
08:43AM	Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR THV to be Presented at TCT 2025 (GlobeNewswire)
Oct-15-25 09:18AM	Anteris Receives First European Regulatory Clearance to Commence DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") (GlobeNewswire)
02:30AM	Loading…
Sep-19-25 02:30AM	Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders (GlobeNewswire)
Sep-11-25 08:50AM	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders (GlobeNewswire)
Sep-04-25 01:42AM	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders (GlobeNewswire)
Aug-11-25 04:52PM	Anteris Announces Results for the Second Quarter of 2025 (GlobeNewswire) +6.00%
Jul-29-25 10:23AM	Anteris (AVR) Welcomes Two Directors as Major Trial Approaches (Insider Monkey)
Jun-09-25 10:52PM	Anteris Appoints David Roberts and Gregory Moss to its Board of Directors (GlobeNewswire) +13.29%
May-13-25 05:45PM	Anteris Announces Results for the First Quarter of 2025 (GlobeNewswire) -9.89%
Mar-31-25 07:15AM	Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV (GlobeNewswire)
Mar-21-25 07:30AM	Anteris Reports One-Year Patient Outcomes for DurAVR THV (GlobeNewswire) -10.16%
Mar-12-25 08:33PM	Anteris Reports 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -6.18%
Feb-28-25 08:00AM	Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays (GlobeNewswire)
Dec-16-24 07:49PM	Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering (Business Wire)
Dec-12-24 10:34PM	Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering (Business Wire)

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seaberg John D	Director	Mar 06 '25	Option Exercise	7.13	40,000	285,200	40,000	Mar 20 07:43 PM
Paterson Wayne	Chief Executive Officer	Mar 05 '25	Option Exercise	7.13	233,000	1,661,290	233,000	Mar 20 07:40 PM
Denaro Stephen	Director	Mar 11 '25	Option Exercise	7.13	16,500	117,645	23,722	Mar 20 07:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Anteris Technologies Global Corp

Upgrade your FINVIZ experience